Senti Biosciences revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNTI annual revenue was $0.0, with -100% growth year-over-year.
SNTI past revenue growth
How has SNTI's revenue growth performed historically?
Senti Biosciences (NASDAQ: SNTI) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Senti Biosciences's revenue was $0.00.
What was Senti Biosciences's revenue in 2024?
Senti Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
How much does Senti Biosciences make in a day?
Based on Senti Biosciences annual revenue for the past four years, SNTI makes an average of $6,580.82 per day.
What was Senti Biosciences's annual revenue growth in the past year?
As of Q2 2025, Senti Biosciences's revenue has grown -100% year over year. This is 597.69 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Senti Biosciences's revenue in the past year totaled $0.00.
How much does Senti Biosciences make in a year?
Senti Biosciences's revenue by year for the past four years is:
Senti Biosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
Senti Biosciences's annual revenue for Dec 31, 2023 was $2.56 million, a 40.25% decrease from 2022.
Senti Biosciences's annual revenue for 2022 was $4.29 million, a 55.23% increase from 2021.
Senti Biosciences's annual revenue for 2021 was $2.76 million, a 387.81% increase from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.